NCT02840240View on ClinicalTrials.gov

Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

April 23, 2021

Conditions
Pain
Interventions
DRUG

Gabapentin enacarbil

600 mg BID 1 day pre-op and 2 hours before surgery, 6 hours after surgery, 600 mg BID 3 days post-operative

DRUG

Placebo

600 mg BID taken 1 day pre-op and 2 hours before surgery, 6 hours after surgery, 600 mg 3 days post-operative

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT02840240 - Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores | Biotech Hunter | Biotech Hunter